
Please try another search
Profusa, Inc. develops bioengineered sensors that are designed to become one with the body to detect and continuously transmit clinical-grade data for personal and medical use. The company offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. It also researches and develops the Lumee Glucose Platform to monitor glucose levels in interstitial fluid. The company is based in Berkeley, California.
Name | Age | Since | Title |
---|---|---|---|
Fred S. Knechtel | 64 | 2025 | CFO & Director |
Ben Chung-Bin Hwang | 57 | 2012 | CEO & Chairman |
Peter O'Rourke | 53 | 2025 | Lead Independent Director |
Rajesh J. Asarpota | 58 | 2025 | Independent Director |
Haeyong Chung | 49 | 2025 | Independent Director |
Jack E. Stover | 72 | 2025 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review